Resources

Sharing knowledge about promising practices and their sustainable implementation is vital to ending the opioid crisis. Our resources include the recommendations of experts and the perspectives of those on the frontlines.

COVID-19

CA Bridge: MOUD and COVID-19 National Emergency Response

March 16, 2020

Guidance on how medications for opioid use disorder (MOUD) services must take immediate action to care for OUD patients while also slowing COVID-19 spread by implementing social distancing into all aspects of care.

arrow-icn

COVID-19

SAMHSA: COVID-19 Guidance for Opioid Treatment Programs

March 16, 2020

The Substance Abuse and Mental Health Services Administration (SAMHSA) provides guidance on pharmacotherapy for opioid use disorder availability in circumstances in which patients may be exposed to highly contagious infectious agents (such as COVID-19).

arrow-icn

COVID-19

DEA: Narcotic Treatment Programs Exception to 21 CFR 1301.74(i)

March 16, 2020

The Drug Enforcement Administration (DEA) has granted narcotic treatment programs (NTPs) an exception to 21 CFR 1301.74(i) in order to provide consistent dosing to patients enrolled.

arrow-icn

COVID-19

NIDA: Potential Implications for Individuals with Substance Use Disorders

March 12, 2020

Nora Volkow, M.D., Director of the National Institute on Drug Abuse (NIDA), highlights the added risks that populations with substance use disorder face during the COVID-19 pandemic.

arrow-icn

Program Advisory Meeting

Delivery System and Payment Models

July 10, 2019

Expert advisory meeting convened by FORE to consider the healthcare delivery system and payment model changes that are needed to facilitate access to treatment.

arrow-icn

Program Advisory Meeting

Medical Education and Training

June 26, 2019

Expert advisory meeting convened by FORE to explore opportunities in medical education and training related to preventing, screening, and treating opioid use disorder.

arrow-icn